On the other hand, TNF-α and IL-1 increase the binding of low density lipoproteins (LDL) to endothelium and smooth muscle, up-regulating the LDL receptor gene, inducing endothelial dysfunction and smooth muscle cell proliferation (33). The gene discussed is TNF; the disease is endothelial dysfunction.